MegaPro Biomedical’s new cell therapy drug MPB-2354 was announced at the World Society of Molecular Imaging
EQS Newswire / 23/10/2024 / 11:34 UTC+8 A new nanodrug development company - MegaPro Biomedical Co., Ltd. (hereinafter referred to as "MegaPro", Taiwan OTC Stock Code: 6827) announced today that Dr. Hsu Yuanhung, vice president of the R&D Department, will head to Oslo, Norway on behalf of MegaPro to participate…

















